Neurogene (NASDAQ:NGNE) Given Outperform Rating at William Blair
William Blair restated their outperform rating on shares of Neurogene (NASDAQ:NGNE – Free Report) in a report published on Tuesday morning,RTT News reports. Separately, HC Wainwright reduced their price target on Neurogene from $55.00 to $50.00 and set a “buy” rating for the company in a report on Tuesday. Seven equities research analysts have rated […]
William Blair restated their outperform rating on shares of Neurogene (NASDAQ:NGNE – Free Report) in a report published on Tuesday morning,RTT News reports. Separately, HC Wainwright reduced their price target on Neurogene from $55.00 to $50.00 and set a “buy” rating for the company in a report on Tuesday. Seven equities research analysts have rated […]
